Severity of Pneumonia in Under 5-Year-Old Children from Developing Countries: A Multicenter, Prospective, Observational Study

Pneumonia is the leading cause of death in children. The objectives were to evaluate the microbiological agents linked with hypoxemia in hospitalized children with pneumonia from developing countries, to identify predictors of hypoxemia, and to characterize factors associated with in-hospital mortal...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of tropical medicine and hygiene Vol. 97; no. 1; pp. 68 - 76
Main Authors Bénet, Thomas, Picot, Valentina Sanchez, Awasthi, Shally, Pandey, Nitin, Bavdekar, Ashish, Kawade, Anand, Robinson, Annick, Rakoto-Andrianarivelo, Mala, Sylla, Maryam, Diallo, Souleymane, Russomando, Graciela, Basualdo, Wilma, Komurian-Pradel, Florence, Endtz, Hubert, Vanhems, Philippe, Paranhos-Baccalà, Gláucia, For The Gabriel Network
Format Journal Article
LanguageEnglish
Published United States American Society of Tropical Medicine and Hygiene 01.07.2017
The American Society of Tropical Medicine and Hygiene
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Pneumonia is the leading cause of death in children. The objectives were to evaluate the microbiological agents linked with hypoxemia in hospitalized children with pneumonia from developing countries, to identify predictors of hypoxemia, and to characterize factors associated with in-hospital mortality. A multicenter, observational study was conducted in five hospitals, from India (Lucknow, Vadu), Madagascar (Antananarivo), Mali (Bamako), and Paraguay (San Lorenzo). Children aged 2-60 months with radiologically confirmed pneumonia were enrolled prospectively. Respiratory and whole blood specimens were collected, identifying viruses and bacteria by real-time multiplex polymerase chain reaction (PCR). Microbiological agents linked with hypoxemia at admission (oxygen saturation < 90%) were analyzed by multivariate logistic regression, and factors associated with 14-day in-hospital mortality were assessed by bivariate Cox regression. Overall, 405 pneumonia cases (3,338 hospitalization days) were analyzed; 13 patients died within 14 days of hospitalization. Hypoxemia prevalence was 17.3%. Detection of human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) in respiratory samples was independently associated with increased risk of hypoxemia (adjusted odds ratio [aOR] = 2.4, 95% confidence interval [95% CI] = 1.0-5.8 and aOR = 2.5, 95% CI = 1.1-5.3, respectively). Lower chest indrawing and cyanosis were predictive of hypoxemia (positive likelihood ratios = 2.3 and 2.4, respectively). Predictors of death were detection by blood PCR (crude hazard ratio [cHR] = 4.6, 95% CI = 1.5-14.0), procalcitonin ≥ 50 ng/mL (cHR = 22.4, 95% CI = 7.3-68.5) and hypoxemia (cHR = 4.8, 95% CI = 1.6-14.4). These findings were consistent on bivariate analysis. hMPV and RSV in respiratory samples were linked with hypoxemia, and in blood was associated with increased risk of death among hospitalized children with pneumonia in developing countries.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMCID: PMC5508893
Authors' addresses: Thomas Bénet and Philippe Vanhems, Laboratoire des Pathogènes Emergents, Fondation Mérieux, Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, CNRS UMR5308, ENS de Lyon, UCBL1, Lyon, France, and Service d'Hygiène, Epidémiologie et Prévention, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France, E-mails: thomas.benet@chu-lyon.fr and philippe.vanhems@chu-lyon.fr. Valentina Sanchez Picot, Florence Komurian-Pradel, Hubert Endtz, and Gláucia Paranhos-Baccalà, Laboratoire des Pathogènes Emergents, Fondation Mérieux, CIRI, INSERM U1111, CNRS UMR5308, ENS de Lyon, UCBL1, Lyon, France, E-mails: valentina.picot@fondation-merieux.org, florence.pradel@fondation-merieux.org, hubert.endtz@fondation-merieux.org, and glaucia.baccala@biomerieux.com. Shally Awasthi and Nitin Pandey, Chhatrapati Shahu Ji Maharaj University, Lucknow, India, E-mails: shally07@gmail.com and drnitinpandey@gmail.com. Ashish Bavdekar and Anand Kawade, KEM Hospital Research Centre, Pune, India, E-mails: bavdekar@vsnl.com and askawade@yahoo.com. Annick Robinson, Hôpital Femme-Mère-Enfant, Antananarivo, Madagascar, E-mail: annicklalaina@yahoo.fr. Mala Rakoto-Andrianarivelo, Fondation Mérieux, Centre d'Infectiologie Charles Mérieux (CICM), Antananarivo, Madagascar, E-mail: mala@cicm-madagascar.com. Maryam Sylla, Gabriel Touré Hospital, Bamako, Mali, E-mail: dr_mame@yahoo.fr. Souleymane Diallo, Centre d'Infectiologie Charles Mérieux (CICM), Bamako, Mali, E-mail: souleymane.diallo@fondationmerieux-mali.org. Graciela Russomando, Health Research Institute, Asuncion, Paraguay, E-mail: grusso@rieder.net.py. Wilma Basualdo, Hospital Pediátrico “Niños de Acosta Ñu,” San Lorenzo, Paraguay, E-mail: wilmabasualdo@gmail.com.
Financial support: This study was funded by Fondation Mérieux and the GABRIEL Network.
ISSN:0002-9637
1476-1645
DOI:10.4269/ajtmh.16-0733